Brett K. Haumann, SVP Clin Development & Chief Med Ofc at Theravance Biopharma, Inc. (TBPH), sold 4,491 shares at $27.99 ($126K) on 2016-08-25, disclosed to the SEC on 2016-08-25.
Open-market sale of $126k TBPH by SVP Clin Development & Chief Med Ofc. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TBPH | SELL | 2016-08-23 | $266K | — | Filing → |